In PTC, there is a significant association between BRAF mutation and extrathyroidal extension, lymph node metastasis, advanced tumor stage, disease recurrence, and even patient mortality.[30] In bioinformatics analysis, we also found the expression level of CLU has a significantly negative correlation with BRAF mutation in thyroid cancer. Here, CLU is linked to neoplasm.